Schleifer Leonard S's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed May 15, 2024
- Accession no.
- 0001883850-24-000022
- Filed
- May 15, 2024
- Trade date
- May 13-15, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions and 1 derivative transaction. Open-market sales total $35.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schleifer Leonard SCIK 0001218629 | Director, Officer (Bd. Co-Chair, President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | Common Stock | MOption exerciseAcquired | +203,204 | $399.66 | +$81,212,510.64 | 577,633 | Direct | |
| May 13, 2024 | Common Stock | FTax withholdingDisposed | −144,433 | $976.79 | −$141,080,710.07 | 433,200 | Direct | |
| May 14, 2024 | Common Stock | SSaleDisposed | −22,698 | $979.16F2 | −$22,224,973.68 | 410,502 | Direct | |
| May 14, 2024 | Common Stock | SSaleDisposed | −2,302 | $980.10F3 | −$2,256,190.2 | 408,200 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −7,864 | $979.05F4 | −$7,699,249.2 | 400,336 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −295 | $980.64F5 | −$289,288.8 | 400,041 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −1,081 | $981.50F6 | −$1,061,001.5 | 398,960 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −235 | $982.66F7 | −$230,925.1 | 398,725 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −250 | $983.91F8 | −$245,977.5 | 398,475 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −305 | $984.00F9 | −$300,120 | 398,170 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −281 | $985.72F10 | −$276,987.32 | 397,889 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −103 | $986.57F11 | −$101,616.71 | 397,786 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −228 | $987.46F12 | −$225,140.88 | 397,558 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −299 | $988.76F13 | −$295,639.24 | 397,259 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | Common Stock | MOption exerciseDisposed | −203,204 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 22,698 shares of Company stock on May 14, 2024 at prices ranging from $979.00 to $979.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 2,302 shares of Company stock on May 14, 2024 at prices ranging from $980.00 to $980.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 7,864 shares of Company stock on May 15, 2024 at prices ranging from $979.00 to $979.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 295 shares of Company stock on May 15, 2024 at prices ranging from $980.17 to $980.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 1,081 shares of Company stock on May 15, 2024 at prices ranging from $981.09 to $981.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 235 shares of Company stock on May 15, 2024 at prices ranging from $982.31 to $982.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 250 shares of Company stock on May 15, 2024 at prices ranging from $983.82 to $983.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 305 shares of Company stock on May 15, 2024 at prices ranging from $984.00 to $984.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 281 shares of Company stock on May 15, 2024 at prices ranging from $985.13 to $985.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F11
Represents volume-weighted average price of sales of 103 shares of Company stock on May 15, 2024 at prices ranging from $986.37 to $986.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F12
Represents volume-weighted average price of sales of 228 shares of Company stock on May 15, 2024 at prices ranging from $987.31 to $987.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F13
Represents volume-weighted average price of sales of 299 shares of Company stock on May 15, 2024 at prices ranging from $988.00 to $988.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.